Bortezomib-induced lupus erythematosus tumidus.
Böckle
Barbara C
BC
Department of Dermatology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. Barbara.boeckle@i-med.ac.at.
Baltaci
Mehmet
M
Weyrer
Walpurga
W
Sepp
Norbert T
NT
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D011719:Pyrazines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib